The findings were published in Molecular Psychiatry

What if individual variations in brain structure could predict a young person’s tendency towards impulsive behaviors, offering early insights into mental health risks? New research from scientists at Northwell Health’s Feinstein Institutes for Medical Research has identified distinct neuroanatomical patterns that predict individual differences in impulsivity across youth. Published in Molecular Psychiatry, the study reveals how specific brain regions and networks are associated with various dimensions of impulsivity, suggesting new avenues for understanding and addressing psychiatric conditions.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260327044052/en/

Dr. Elvisha Dhamala led the study. (Credit: Feinstein Institutes)

This discovery, led by Elvisha Dhamala, PhD, assistant professor in the Institute of Behavioral Science at the Feinstein Institutes, advances the understanding of the complex interplay between brain structure and behavior during a critical developmental period. While impulsivity is a common feature in many psychiatric illnesses and undergoes changes during adolescence, the precise structural underpinnings contributing to its diverse manifestations have remained largely unexplored. By employing machine learning across a large, longitudinal dataset, researchers have mapped these intricate brain-behavior relationships.

Using brain-based predictive models and data from the Adolescent Brain Cognitive Development (ABCD) Study, the team analyzed multiple neuroanatomical features – including cortical thickness, surface area and gray matter volume – and self-reported measures of impulsivity from over 8,600 youth across several developmental timepoints. The study found that regional variations in these brain features significantly predict different dimensions of impulsivity, such as drive, urgency, lack of planning and behavioral inhibition. Notably, these associations broadly mapped onto key brain networks including the default mode, limbic, ventral attention and visual networks, as well as cerebellar and brain stem structures. The research also revealed sex-specific patterns, indicating that the neuroanatomical basis of impulsivity is not static but changes with development and varies between males and females. While individual differences in stable brain organization proved predictive, longitudinal changes in neuroanatomy were not as strongly associated with changes in impulsivity, suggesting that a young person’s overall brain structure may be a more consistent indicator of their behavioral tendencies than short-term structural changes.

“Our findings reveal that the brain’s physical structure holds clues to understanding why individuals exhibit different levels and types of impulsivities,” said Dr. Dhamala. “This research not only deepens our understanding of the brain’s role in decision-making and emotional regulation but also highlights that impulsivity is not a single trait, but a complex interplay of various neural patterns that evolve over time and differs between sexes.”

These insights have clinical implications, especially given that heightened impulsivity is a core characteristic of many psychiatric disorders, including attention-deficit/hyperactivity disorder (ADHD), substance use disorder, and mood disorders. Identifying these neuroanatomical signatures can inform the development of more precise diagnostic tools and personalized early interventions. By understanding which brain structures are most implicated in specific aspects of impulsivity, clinicians may one day be able to tailor treatments that target these unique neurobiological underpinnings.

“Precision mental health care demands we deeply understand the developing brain. Dr. Dhamala’s research precisely uncovers the neurobiological wiring behind impulsivity in youth,” said Anil K. Malhotra, MD, co-director of Institute of Behavioral Science at the Feinstein Institutes. “This knowledge can open pathways for targeted diagnostics and personalized interventions, informing our search to create device-based therapies that re-engineer these circuits for better lives.”

About the Feinstein Institutes
The Feinstein Institutes for Medical Research is the home of the research institutes of Northwell Health, the largest health care provider and private employer in New York State. Encompassing 50+ research labs, 3,000 clinical research studies and 5,000 researchers and staff, the Feinstein Institutes raises the standard of medical innovation through its six institutes of behavioral science, bioelectronic medicine, cancer, health system science, molecular medicine, and translational research. We are the global scientific leader in bioelectronic medicine – an innovative field of science that has the potential to revolutionize medicine. The Feinstein Institutes publishes two open-access, international peer-reviewed journals Molecular Medicine and Bioelectronic Medicine. Through the Elmezzi Graduate School of Molecular Medicine, we offer an accelerated PhD program. For more information about how we produce knowledge to cure disease, visit http://feinstein.northwell.edu and follow us on LinkedIn.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260327044052/en/